# PT 20210 {-}

## **Overview of Prothrombin G20210A Mutation Testing** {-}

*   **Definition:** Molecular testing for the prothrombin G20210A mutation involves detecting a specific genetic variation in the prothrombin (*F2*) gene
*   **Clinical Significance:**
    *   Assesses the Prothrombin Mutation in the Body
    *   Evaluation of Thrombotic Risk
*   **Key Points:**
    *   Molecular Test: The most common way to detect and analyze
    *   No Cure: Not everyone gets all of the issues with the disorder, it just implies that it is more easy for patients with the mutation to develop

## **The *F2* Gene and Prothrombin G20210A Mutation** {-}

*   **The *F2* Gene:**
    *   Location: Chromosome 11 (11p11.2)
    *   Encodes: Prothrombin (Factor II), a vitamin K-dependent coagulation factor that is converted to thrombin by the prothrombinase complex
*   **The Prothrombin G20210A Mutation:**
    *   Description: A point mutation in the 3'-untranslated region (3'UTR) of the *F2* gene
    *   Nucleotide Change: A guanine (G) to adenine (A) substitution at position 20210 (G20210A)
    *   Effect on Prothrombin Levels: The mutation leads to increased prothrombin mRNA stability, resulting in elevated plasma prothrombin levels

## **Molecular Testing Procedures** {-}

The general procedure for detecting the prothrombin G20210A mutation involves the following steps:

1.  **DNA Extraction:**
    *   Extract DNA from a blood sample (typically EDTA whole blood) using a commercially available DNA extraction kit
    *   Ensure that the DNA is of high quality and free from inhibitors
    
2.  **PCR Amplification:**
    *   Use the polymerase chain reaction (PCR) to amplify a specific region of the *F2* gene that contains the G20210A mutation
    *   Use primers that flank the region of interest and are specific for the *F2* gene
    
3.  **Mutation Detection:**
    *   Allele-Specific PCR (AS-PCR):
        *   Uses primers that are specific for either the normal sequence or the mutated sequence
        *   The presence of a PCR product indicates the presence of that specific allele
    *   Restriction Fragment Length Polymorphism (RFLP) Analysis:
        *   Uses a restriction enzyme that recognizes and cuts the normal DNA sequence but does not cut the mutated sequence
        *   The PCR product is digested with the restriction enzyme, and the resulting fragments are analyzed by gel electrophoresis
        *   The presence of different fragment sizes indicates the presence of the prothrombin G20210A mutation
    *   Real-Time PCR (qPCR):
        *   Uses fluorescent probes to detect the amplified DNA product in real time
        *   Can be used to quantify the amount of the normal and mutated alleles
    *   Next-Generation Sequencing (NGS):
        *   Can be used to sequence the entire *F2* gene and identify both known and novel mutations
        *   Less commonly used for routine prothrombin G20210A testing, but may be useful in cases with atypical presentations

## **Interpreting Results** {-}

*   **Normal (Homozygous Wild-Type):** The patient has two copies of the normal *F2* gene and does not carry the prothrombin G20210A mutation
*   **Heterozygous:** The patient has one copy of the normal *F2* gene and one copy of the prothrombin G20210A mutated gene
    *   Increased risk of venous thrombosis
*   **Homozygous:** The patient has two copies of the prothrombin G20210A mutated gene
    *   Higher risk of venous thrombosis compared to heterozygotes
*   *Important Notes:*
    *   The interpretation of results should always be made in the context of the patient's clinical history, family history, and other laboratory findings
    *   Patients with prothrombin G20210A mutation are at risk for high prothrombin levels
    *   Increased risk of venous thromboembolism
    *   Pregnancy loss
    *   Arterial thrombotic events (less common)

## **Factors Affecting Test Results** {-}

*   **Pre-Analytical Variables:**

    *   Sample Collection:
        *   Collect blood in an EDTA (purple-top) tube
        *   Avoid clots or hemolysis
    *   Sample Storage:
        *   Store samples properly to prevent DNA degradation

*   **Analytical Variables:**

    *   Reagent Quality:
        *   Use high-quality reagents and ensure that they are not expired
    *   Proper Controls:
        *   Include positive and negative controls in each PCR run to monitor the performance of the assay

*   **Patient-Related Variables:**

    *   Recent Blood Transfusion:
        *   May affect results if the transfused blood contains a different *F2* genotype than the patient's own cells
        *   Wait several weeks after transfusion before performing the test

## **Troubleshooting Erroneous Results** {-}

*   If the molecular test results are unexpected or inconsistent with the patient's clinical presentation:

    *   Verify the sample identity and chain of custody
    *   Repeat the test on a fresh sample
    *   Check the quality control data for the assay
    *   Investigate potential interfering substances or technical errors
    *   Consider the possibility of a rare or novel *F2* mutation

## **Reflex Testing** {-}

There generally isn't a reflex test, as the F2/Prothrombin mutation is generally either present or not. However, after finding the mutation, you might:
*   Run protein levels to evaluate how much Prothrombin the patient is making
*   Other tests may be used for other thrombophilias

## **Key Terms** {-}

*   ***F2* Gene:** The gene that encodes prothrombin (Factor II)
*   **Prothrombin G20210A Mutation:** A genetic mutation in the 3'-untranslated region of the *F2* gene
*   **Thrombophilia (Hypercoagulable State):** An increased tendency to develop blood clots
*   **Venous Thromboembolism (VTE):** A condition that includes deep vein thrombosis (DVT) and pulmonary embolism (PE)
*   **Allele-Specific PCR (AS-PCR):** A PCR technique that uses primers specific for either the normal or mutated sequence
*   **Restriction Fragment Length Polymorphism (RFLP):** A technique that uses restriction enzymes to cut DNA at specific sites
*   **Real-Time PCR (qPCR):** A PCR technique that allows for the quantification of the amplified DNA product
